| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Sep 10, 2024 | Option Exercise | $12.88 | 8,000 | 103,040 | 20,000 | Sep 12, 2024, 07:38 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Sep 10, 2024 | Sale | $45.00 | 8,000 | 360,000 | 12,000 | Sep 12, 2024, 07:38 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Jul 24, 2024 | Option Exercise | $12.88 | 8,000 | 103,040 | 20,000 | Jul 26, 2024, 04:31 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Jul 24, 2024 | Sale | $40.00 | 8,000 | 320,000 | 12,000 | Jul 26, 2024, 04:31 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Jun 07, 2024 | Option Exercise | $12.88 | 8,000 | 103,040 | 20,000 | Jun 11, 2024, 04:30 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Jun 07, 2024 | Sale | $35.00 | 8,000 | 280,000 | 12,000 | Jun 11, 2024, 04:30 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Mar 01, 2024 | Option Exercise | $6.09 | 12,975 | 79,018 | 24,975 | Mar 01, 2024, 08:45 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | Mar 01, 2024 | Sale | $31.34 | 12,975 | 406,637 | 12,000 | Mar 01, 2024, 08:45 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 11, 2024 | Sale | $38.07 | 3,934 | 149,759 | 49,170 | Jan 16, 2024, 06:06 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Dec 15, 2023 | Option Exercise | $25.41 | 14,987 | 380,820 | 51,804 | Dec 19, 2023, 03:41 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 09, 2023 | Sale | $30.00 | 3,200 | 96,000 | 28,950 | Jan 11, 2023, 08:23 PM | |
| PTGX | Protagonist Therapeutics, Inc | Waddill William D. | Director | May 03, 2022 | Option Exercise | $8.59 | 12,000 | 103,080 | 12,000 | May 04, 2022, 08:41 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 03, 2022 | Sale | $64.72 | 4,500 | 291,244 | 28,150 | Jan 04, 2022, 09:35 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 04, 2021 | Sale | $76.08 | 3,750 | 285,300 | 30,250 | Jan 05, 2021, 06:01 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Dec 10, 2020 | Sale | $71.26 | 3,000 | 213,780 | 26,800 | Dec 11, 2020, 06:16 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | May 11, 2020 | Sale | $36.54 | 26,000 | 950,040 | 28,000 | May 13, 2020, 06:45 PM | |
| ARWR | ARROWHEAD PHARMACEUTICALS, INC. | Waddill William D. | Director | Jan 11, 2019 | Sale | $14.77 | 8,500 | 125,545 | 46,500 | Jan 11, 2019, 06:15 PM | |
| CALA | Calithera Biosciences, Inc. | Waddill William D. | SR. VP & CFO | Jul 14, 2015 | Option Exercise | $2.64 | 13,125 | 34,650 | 15,625 | Jul 16, 2015, 05:41 PM | |
| CALA | Calithera Biosciences, Inc. | Waddill William D. | SENIOR VP & CFO | Dec 16, 2014 | Option Exercise | $3.43 | 6,797 | 23,284 | 16,172 | Dec 18, 2014, 05:19 PM |
Menu